Evaluation of biomarkers and surrogate endpoints in chronic disease /
"Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in ord...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | Book |
| Language: | English |
| Published: |
Washington, D.C. :
National Academies Press,
[2010]
|
| Subjects: |
Table of Contents:
- Review : evaluating and regulating biomarker use
- The biomarker evaluation process
- Case studies-- Strengthening evidence-based regulation.